Jane Street
ACET icon

Jane Street’s Adicet Bio ACET Stock Holding History

Jane Street’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-9,413
Closed -$2.14M – 9018
2022
Q3 		$2.14M Buy
+9,413
New +$2.39M ﹤0.01% 4091

Other funds holding ACET

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Jane Street's ACET Position: Q1 2026 in Review

Jane Street opened a new position in Adicet Bio (ACET) in Q1 2026: 37,084 shares worth $253K. The stake represents ﹤0.01% of the portfolio and ranks #9608 among its holdings. This is a return to the name: Jane Street previously reported a position in ACET as recently as Q3 2025.

Jane Street first reported a position in ACET in Q1 2019 and has held it in 14 quarters since. The position peaked at $3.02M in Q3 2022. 49 funds tracked by Wall St. Rank hold ACET as of Q1 2026.

  • Jane Street held 37,084 shares of Adicet Bio worth $253K as of Q1 2026.
  • Adicet Bio was a new Jane Street position in Q1 2026.
  • Adicet Bio made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #9608 holding.
  • Jane Street first reported a position in Adicet Bio in Q1 2019 and has held it in 14 quarters since.
  • Jane Street's Adicet Bio position peaked at $3.02M in Q3 2022.
  • 49 funds tracked by Wall St. Rank held Adicet Bio as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.